Form 4: FibroGen SVP Christine Chung Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Christine Chung, SVP of China Operations at FibroGen, disposed of 19,289 shares of common stock on June 6, 2024, to cover tax obligations related to vesting restricted stock units.
Summary
- On June 6, 2024, Christine Chung, the SVP of China Operations at FibroGen, disposed of 19,289 shares of FibroGen common stock.
- The transaction was executed at a price of $1.19 per share.
- The disposal was to cover the tax obligation realized upon the vesting of restricted stock units.
- Following the transaction, Christine Chung beneficially owns 321,739 shares of FibroGen common stock.
Sentiment
Score: 5
Explanation: This is a routine transaction related to tax obligations, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 06/06/2024 | Date of transaction: Christine Chung disposed of shares. |
| 06/07/2024 | Date of signature: Michael Hom, Attorney-in-Fact, signed the document. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.